Research and experimental development on natural sciences and engineering
ORPHAN DIAGNOSTICS AS
Revenue 2024
NOK 479,000
Operating profit
NOK 181,000
Equity
NOK −307,000
Incorporated
2016
Share capital
NOK 69,000
Roles
Daglig lederKnut Erik Hovda
Regnskapsfører
Styrets lederErik Gill Skaarnæs
StyremedlemKnut Erik Hovda
StyremedlemTor Aagaard Borgersen
StyremedlemFridtjof Heyerdahl
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| ORPHAN MEDICAL AS | 31.5% | 21856.000000 | 2025 |
| KNUT ERIK HOVDA | 18.6% | 12919.000000 | 2025 |
| DRUBION AS | 12.8% | 8859.000000 | 2025 |
| MALSEN MEDICAL AS | 10.8% | 7467.000000 | 2025 |
| FRIHEY AS | 9.1% | 6314.000000 | 2025 |
| TOR AAGAARD BORGERSEN | 4.7% | 3271.000000 | 2025 |
| NEMSESK AS | 3.9% | 2680.000000 | 2025 |
| MEDCON AS | 3.2% | 2193.000000 | 2025 |
| KAI VIDAR MOE | 2.4% | 1659.000000 | 2025 |
| ÅSMUND RØHR KJENDSETH | 1.9% | 1325.000000 | 2025 |
| DAG JACOBSEN | 1.1% | 767.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.